New PTSD Treatments: Drugs in Development & Pharmacological Targets
Post-traumatic stress disorder (PTSD) continues to afflict millions worldwide, necessitating more effective therapeutic options. Key Facts: PTSD involves dysfunctional fear processing and altered threat perception. Current treatments fail to comprehensively address its complex symptoms. Research implicates dysregulation in brain systems like the HPA axis and glutamate, presenting novel drug targets. Medications modulating oxytocin, cannabinoids, opioids …
